Policy & Regulation
Xeris Biopharma receives USPTO Notice of Allowance for XP-8121 patent
1 December 2025 - Biopharmaceutical company Xeris Biopharma Holdings Inc (Nasdaq: XERS) announced on Monday that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance ...
Ionis Pharmaceuticals granted FDA Breakthrough Therapy Designation for olezarsen in severe hypertriglyceridemia
1 December 2025 - RNA-targeted medicines company Ionis Pharmaceuticals Inc (Nasdaq: IONS) announced on Monday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designat...
Polarean expands XENOVIEW 3T Coil access with Philips compatibility
1 December 2025 - Medical imaging technology company Polarean Imaging plc (AIM: POLX) reported on Monday that its FDA-cleared XENOVIEW 3T Chest Coil has passed Philips' compatibility testing, con...
Avandra Health acquires DatCard Systems and Sorna Corporation
1 December 2025 - Avandra Health, a federated network for medical imaging and clinical data, announced on Sunday that it has acquired healthcare technology company DatCard Systems and medical equipmen...
Zentiva receives ESG Transparency Award 2025
1 December 2025 - Zentiva, a Czechia-based generics pharmaceutical company, announced on Friday that it has received the ESG Transparency Award 2025, presented by German market research organisation E...
Immedica gets UAE approval for Zepzelca maintenance treatment
28 November 2025 - Swedish pharmaceutical company Immedica Pharma AB said on Friday that the Zepzelca (lurbinectedin) + Tecentriq (atezolizumab) maintenance regimen is now approved by the Emirates Dru...